Micro Syringes Market Size, Share & Trends Analysis Report By Syringe Type (Autosampler Syringes, Manual Syringes), By End-use (Hospitals, Outpatient Facilities, Research & Manufacturing), By Region, And Segment Forecasts, 2023 - 2030
Micro Syringes Market Growth & Trends
The global micro syringes market size is expected to reach USD 352.8 million by 2030, registering a CAGR of 6.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is growing due to the increased quantity of life science research investigations. It is projected that the market will be driven by an increasing number of drug observations, preclinical research, and clinical trials due to pharmaceutical and biomedical companies’ increased attempts to produce efficient products. The need for micro syringes is growing due to the pharmaceutical industry's extensive research efforts to create new medications.
Government funding for primary and initial researches also promotes commercial expansion. For instance, recently, there has been a noticeable diversity and increase of the injectable eye drug pipeline. This extension also includes a greater range of dose frequencies, additional delivery channel options (such as suprachoroidal and subretinal), and other target disorders (such as global atrophy and diabetic macular edema). As a result, new delivery requirements have arisen, such as limiting silicone that leaches, handling viscous formulations, and attaining microliter dose accuracy.
Micro Syringes Market Report Highlights
Based on syringe type, the autosampler syringes segment accounted for the largest revenue share of over 60.0% in 2022, and is expected to grow at the fastest CAGR of 6.4% over the forecast period. Due to the growing acceptance of precision autosamplers, the market is growing
Based on end-use, the hospitals segment accounted for the largest revenue share of around 47.0% in 2022. Different types of micro syringes are frequently needed in hospitals to accommodate various medical specializations, including diagnostics, anesthesia, and oncology
The outpatient facilities segment is expected to grow at the fastest CAGR of 6.5% over the forecast period. The growing tendency toward ambulatory services and outpatient care is in line with the flexibility and convenience of outpatient facilities
North America dominated the market with a revenue share of over 40.0% due to the rising prevalence of chronic illnesses and advancements in healthcare technologies. Asia Pacific is anticipated to grow at the fastest CAGR of 7.6% over the forecast period with countries such as China and India serving as significant centers for pharmaceutical production and research
Please note The report will be delivered in 2-3 business days upon order notification.